Studies related to Depression and Red Clover Extract

Improvement Of Postmenopausal Depressive And Anxiety Symptoms After Treatment With Isoflavones Derived From Red Clover Extracts

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 109
Gender Female
Age Range 45-64
Notes for this study:
Symptoms of anxiety (Hospital Anxiety and Depression Scale) and depression (Zung's Self Rating Depression Scale) in menopausal women given 80mg of MF11RCE supplementation daily was able to reduce anxiety (76.9%) and depression (78.3-80.6%) relative to placebo, which declined 21.7% on average.
Funding issues for this study:
Funded by the producers of MF11RCE

Full details on all 1 studies are available to Examine Plus members.

Already a member? Login now to access.